Get started
Author

Takehiro Ohnuma

Observed name: Takehiro Ohnuma (18949697)
ORCID: 0009-0005-4223-4547
Observed ORCID: 0009-0005-4223-4547
OpenAlex ID: A5045307530
Immune evasion through mitochondrial transfer in the tumour microenvironment
2025 · Hideki Ikeda, Katsushige Kawase, et al. · Nature · 323
PDF
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes
2022 · Joji Nagasaki, Takashi Inozume, et al. · Cell Reports · 118
TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment
2021 · Shusuke Kawashima, Takashi Inozume, et al. · Journal for ImmunoTherapy of Cancer · 83
PDF
Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti–PD-1 Therapy
2019 · Takashi Inozume, Tomonori Yaguchi, et al. · Journal of Investigative Dermatology · 26
PDF
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2022 · Takao Morinaga, Takashi Inozume, et al. · Cancer Research Communications · 17
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2024 · Yuto Naoi, Takao Morinaga, et al. · Cancer Research · 11
Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment
2025 · Hideki Ikeda, Katsushige Kawase, et al. · Nature · 7
PDF
Case of anal adenocarcinoma in situ with pagetoid spread but without macroscopic abnormality in anal mucosa
2016 · Takae Shimizu, Takashi Inozume, et al. · The Journal of Dermatology · 7
Case of CIC‐DUX4 sarcoma of the skin: Histological simulant of epithelioid angiosarcoma
2021 · Eri Maejima, Hiroshi Mitsui, et al. · The Journal of Dermatology · 5
Acute generalized exanthematous pustulosis associated with anti-interferon-γ neutralizing autoantibody-positive disseminated nontuberculous mycobacterial infection
2019 · Youichi Ogawa, Ryo Hasebe, et al. · European Journal of Dermatology · 5
PDF
Immunopeptidomics combined with full-length transcriptomics uncovers diverse neoantigens
2025 · Takamasa Ishino, Tomofumi Watanabe, et al. · Cell Reports · 4
Heterogeneity in congenital melanocytic nevi contributes to multicentric melanomagenesis
2020 · Akiko Honobe, Kazuko Sakai, et al. · Journal of Dermatological Science · 3
Case of metastatic uveal melanoma in which an antitumor effect appeared after ipilimumab discontinuation due to autoimmune hypophysitis
2016 · Takehiro Ohnuma, Takamitsu Matsuzawa, et al. · The Journal of Dermatology · 3
Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment
2025 · Hideki Ikeda, Katsushige Kawase, et al. · Nature · 2
PDF
Overexpression of heat shock protein 90 through the downregulation of miR ‐9‐5p in extramammary Paget's disease
2023 · Takehiro Ohnuma, Myangat Tselmeg Mijiddorj, et al. · The Journal of Dermatology · 2
Figure S6 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
Figure S7 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
Figure S1 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
Figure S4 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
TableS2 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
TableS4 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
Figure S3 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
Figure S5 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
TableS3 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
TableS1 from CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2026 · Yuto Naoi, Takao Morinaga, et al.
Works count: 91
Citation count: 615
H-index: 7
I10-index: 6
Year
Topic
Type